PH-0113 Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904)

Authors :: C. Lemanski
Xavier Mirabel
Astrid Lièvre
Philippe Ronchin
Véronique Vendrely
Gilles Breysacher
C. Lepage
Thomas Aparicio
K. Le-Malicot
Nicolas Magné
Ariane Darut-Jouve
E. Thimonier
M. Minsat
C. De La Fouchardiere
C. Belletier
D. Argo-Leignel
Source :: Radiotherapy and Oncology. 161:S82-S83
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: business.industry
Locally advanced
Phases of clinical research
Hematology
Oncology
Anti-Epidermal Growth Factor Receptor
Cancer research
Medicine
Panitumumab
Radiology, Nuclear Medicine and imaging
business
Chemoradiotherapy
medicine.drug
ANAL CANAL CARCINOMA

Full Text Access

Tools